logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
L

Laurent Greillier

aix marseille universite
H指数:41
被引数:9,231

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Using the Geriatric Core Dataset (G-CODE) to predict mortality in older patients with cancer: development and external validation

使用老年核心数据集（G-CODE）预测肿瘤老年患者的死亡率：开发与外部验证

British Journal of Cancer
IF6.8
2026-10-120
OAAI
Anne-Laure Couderc; Claudia Martinez-Tapia; Simone Mathoulin-Pelissier; Marie Laurent; Michael Bringuier; Pierre Gay; Philippe Caillet; Jeanne Bertona; Laurent Greillier; Johanna Canovas; Pierre Soubeyran; Siri Rostoft; Florence Canouï-Poitrine; Elena Paillaud
Tolerance and Efficacy of Targeted Therapies After Immunotherapy for Advanced Non-Small Cell Lung Cancers Harboring Oncogenic Alterations: The GFPC-TOXIMAD Study

针对携带致癌基因突变型晚期非小细胞肺癌，在免疫疗法后进行靶向治疗耐受性与有效性的研究：GFPC-TOXIMAD研究

Current Oncology
IF3.4
2026-08-300
OA
Thomas Pierret; Jean-Bernard Auliac; Charles Ricordel; Catherine Daniel; Jessica Nguyen; Florian Guisier; Aurélie Swalduz; Hubert Curcio; Anne Laure Desage; Laurence Bigay-Game; Eric Huchot; Lionel Falchero; Hélène Doubre; Olivier Bylicki; Christos Chouaïd; Laurent Greillier
Association of sleep-related hypoxemia with survival in patients with non-small cell lung cancer – the NEOSAS-GFPC study group

睡眠相关低氧血症与无小细胞肺癌患者生存率的相关性——NEOSAS-GFPC研究小组

CHEST
IF8.6
2026-03-090
PRE
Grégoire Justeau; Laurent Greillier; Florent Vinas; Lionel Falchero; Olivier Bylicki; Marie Bernardi; Francis Martin; Isabelle Simon; Didier Debieuvre; Chrystèle Locher; Acya Bizieux-Thaminy; Virginie Levrat; Stéphanie Fry; Camille Guguen; Frédéric Goutorbe; Philippe Masson; Franck Soyez; Christos Chouaid; Patrick Saulnier; Frédéric Gagnadoux
SA63 Lung-Cancer Diagnostic Trajectories: A Nationwide Process-Mining Cluster Analysis of 18,569 French Patients

SA63 肺癌诊断轨迹：一项基于18,569例法国患者 nationwide process-mining cluster analysis（全国过程挖掘聚类分析）的研究

Value in Health
IF6
2025-12-180
PRE
Arnaud Panes; Helene Denis; Lionel Bensimon; Isabelle Durand-Zaleski; Laurent Greillier; Pascal-Alexandre Thomas; Marie Wislez; Alice Brouquet; Marion Apert; Valérie Guimard; Christine Le Bihan Benjamin; Marion Narbeburu; Christos CHOUAID
Real-world efficacy and safety of amivantamab in EGFR exon-20-mutant non-small cell lung cancer in a French early-access program: Amexon 20 GFPC study

法国早期准入项目中阿曼曲单抗在EGFR外显子20突变非小细胞肺癌中的真实世界有效性与安全性：Amexon 20 GFPC研究

Lung Cancer
IF4.4
2025-09-260
PRE
Thomas Pierret; Laurent Greillier; Florian Guisier; Catherine Daniel; Renaud Descourt; Loick Galland; Olivier Molinier; Chantal Decroisette; Alexis Cortot; Diane Moreau; Laurence Bigay Gamé; Marie Wislez; Nicolas Cloarec; Hubert Curcio; Nicolas Delberghe; Jacques Cadranel; Boris Duchemann; Anne Claire Toffart; Christos Chouaïd; Jean-Bernard Auliac
MiR-193b-3p and miR-132-3p as prognostic biomarkers of survival in pleural mesothelioma patients treated with first-line bevacizumab plus pemetrexed-platinum chemotherapy in the IFCT-0701 MAPS phase 3 trial

MiR-193b-3p和miR-132-3p作为IFCT-0701 MAPS III期试验中接受一线贝伐珠单抗联合培美曲塞-铂类化疗的恶性胸膜间皮瘤患者的生存预后生物标志物

Translational Oncology
IF4.1
2025-09-050
PREAI
Guénaëlle Levallet; Christian Creveuil; Alexandre Léger-Vigot; Solenn Brosseau; Claire Danel; Arnaud Scherpereel; Sylvie Lantuejoul; Julien Mazières; Laurent Greillier; Clarisse Audigier-Valette; Emmanuel Bergot; Denis Moro-Sibilot; Olivier Molinier; Hervé Léna; Isabelle Monnet; Franck Morin; Valérie Gounant; Gérard Zalcman
Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trial

仑伐替尼联合帕博利珠单抗治疗经治性转移性B3胸腺瘤和胸腺癌（PECATI）：一项单臂、II期临床试验

lancet oncology
IF0
2025-09-010
PRE
Jordi Remon; Paolo Bironzo; Nicolas Girard; Laurence Bigay-Game; Oscar Juan-Vidal; Javier de Castro; Noemí Reguart; Laurent Greillier; Sophie Cousin; Eric Dansin; Margarita Majem; Reyes Bernabé; Joaquin Mosquera Martinez; Marta Díaz; Alba Meya; Daniel Alcalá-López; Alicia García-Sanz; Luisella Righi; Silvia Novello; Benjamin Besse
Re-biopsy Feasibility and Clinical Impact on Metastatic Non-Small-Cell Lung Cancer with EGFR/ALK/ROS Oncogenic Driver Progression after Optimal Targeted Therapy: A Multicenter Real-World Analysis

再次活检的可行性及在EGFR/ALK/ROS致癌驱动基因进展的转移性非小细胞肺癌经最佳靶向治疗后：一项多中心真实世界分析

Clinical Lung Cancer
IF3.3
2025-08-210
PRE
Antoine Bronstein; Hubert Curcio; Isabelle Monnet; Charles Ricordel; Laurence Bigay-Game; Margaux Geier; Chantal Decroisette; Catherine Daniel; Florian Guisier; Aurélie Swalduz; Anne Claire Toffart; Hélène Doubre; Jean Michel Peloni; Dominique Arpin; Hugues Morel; Remi Veillon; Benedicte Clarisse; Christos Chouaïd; Laurent Greillier; Olivier Bylicki
Adjuvant chemotherapy for stage IA–IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial

根据14基因表达谱被鉴定为分子高危的IA–IIA期非鳞状、非小细胞肺癌的辅助化疗（AIM-HIGH）：一项国际、随机、III期临床试验

The Lancet Respiratory Medicine
IF0
2025-06-240
OAAI
David R Spigel; Virginie Westeel; Ian C Anderson; Laurent Greillier; Florian Guisier; Olivier Bylicki; Firas B Badin; Gaelle Rousseau-Bussac; Clotilde Deldycke; Frank Griesinger; Adam Bograd; Wangjian Zhong; Jacques Le Treut; Sylvie Van Hulst; David R Gandara; Martin Reck; Petra Hoffknecht; Matthew A Gubens; John Crowley; Heiko von der Leyen; Gavitt A Woodard; David M Jablons; Johannes R Kratz; Michael J Mann
First-Line Pembrolizumab Efficacy in Octogenarians With NSCLCs Expressing ≥ 50% PD-L1 (ESCKEYP GFPC 05-2018)

一线帕博利珠单抗在PD-L1表达≥50%的80岁及以上非小细胞肺癌患者中的疗效（ESCKEYP GFPC 05-2018）

Clinical Lung Cancer
IF3.3
2025-03-040
PRE
Romain Corre; Chantal Decroisette; Jean-Bernard Auliac; Lionel Falchero; Hubert Curcio; Karim Amrane; Maurice Perol; Stéphane Hominal; Sabine Vieillot; Eric Huchot; Anne Laure Desage; Marie Bernardi; Remi Veillon; Hélène Doubre; Suzanna Bota; Gwenaelle Legarff; Grégoire Justeau; Oliver Bylicki; Magali Roa; Renaud Descourt; Christos Chouaïd; Laurent Greillier

研究方向

暂未获取到该数据
F
Fabrice Barlési
H 指数:99论文数:1,480被引数:7.1万
P
Pascale Tomasini
H 指数:31论文数:317被引数:4,396
C
C. Chouaïd
H 指数:58论文数:1,032被引数:1.8万
O
Olivier Bylicki
H 指数:22论文数:190被引数:3,626
B
Benjamin Besse
H 指数:100论文数:1,844被引数:5.6万
P
P. Thomas
H 指数:73论文数:812被引数:2.2万
I
I. Monnet
H 指数:56论文数:521被引数:1.3万
J
Julien Mazières
H 指数:91论文数:996被引数:4.8万
C
C. Decroisette
H 指数:19论文数:188被引数:2,112
A
Arnaud Scherpereel
H 指数:66论文数:464被引数:1.8万